JP2006501139A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501139A5
JP2006501139A5 JP2003575926A JP2003575926A JP2006501139A5 JP 2006501139 A5 JP2006501139 A5 JP 2006501139A5 JP 2003575926 A JP2003575926 A JP 2003575926A JP 2003575926 A JP2003575926 A JP 2003575926A JP 2006501139 A5 JP2006501139 A5 JP 2006501139A5
Authority
JP
Japan
Prior art keywords
antibody
tpm
abf
angiogenic
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003575926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501139A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/008060 external-priority patent/WO2003077872A2/en
Publication of JP2006501139A publication Critical patent/JP2006501139A/ja
Publication of JP2006501139A5 publication Critical patent/JP2006501139A5/ja
Pending legal-status Critical Current

Links

JP2003575926A 2002-03-15 2003-03-17 血管形成阻害の標的としての細胞表面トロポミオシン Pending JP2006501139A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36404702P 2002-03-15 2002-03-15
PCT/US2003/008060 WO2003077872A2 (en) 2002-03-15 2003-03-17 Cell surface tropomyosin as a target of angiogenesis inhibition

Publications (2)

Publication Number Publication Date
JP2006501139A JP2006501139A (ja) 2006-01-12
JP2006501139A5 true JP2006501139A5 (https=) 2006-06-15

Family

ID=28041863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003575926A Pending JP2006501139A (ja) 2002-03-15 2003-03-17 血管形成阻害の標的としての細胞表面トロポミオシン

Country Status (7)

Country Link
US (1) US20050124794A1 (https=)
EP (1) EP1575525A4 (https=)
JP (1) JP2006501139A (https=)
AU (1) AU2003218194A1 (https=)
CA (1) CA2478962A1 (https=)
WO (1) WO2003077872A2 (https=)
ZA (1) ZA200407373B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301988D0 (sv) * 2003-07-07 2003-07-07 Innoventus Project Ab Active subfragment of an endogenous peptide
WO2006058375A1 (en) * 2004-12-01 2006-06-08 The Royal Alexandra Hospital For Children Identification of compounds for the treatment of proliferative disorders
DE102005002110A1 (de) * 2005-01-17 2006-07-27 Protagen Ag Regulatorische-T-Zellen enthaltend Proteine zur Therapie und Diagnose von Erkrankungen
WO2007075215A2 (en) 2005-10-21 2007-07-05 Attenuon, Llc Identification of novel protein targets on the surface of stressed cells
KR102874711B1 (ko) 2015-12-15 2025-10-23 다케다 파머수티컬 컴패니 리미티드 전장 고분자량 키니노겐(hmwk) 및 절단된 hmwk를 구별하기 위한 펩타이드 정량화 검정법
EP3634442B1 (en) 2017-05-24 2025-04-09 Tets, Viktor, Veniaminovich Method for diagnosis of parkinson's disease
US12535491B2 (en) 2018-04-30 2026-01-27 Viktor Veniaminovich Tets Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix
US11918610B2 (en) 2018-06-29 2024-03-05 Viktor Veniaminovich Tets Methods for diagnosis and treatment of type 1 diabetes
WO2020010214A1 (en) 2018-07-03 2020-01-09 Tets Viktor Veniaminovich Method for assessing and inhibiting aging and means of determining biological age

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201104B1 (en) * 1998-12-04 2001-03-13 Entremed, Inc. Angiogenesis—inhibiting protein binding peptides and proteins and methods of use
US6342219B1 (en) * 1999-04-28 2002-01-29 Board Of Regents, The University Of Texas System Antibody compositions for selectively inhibiting VEGF
WO2001034195A1 (en) * 1999-11-12 2001-05-17 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US20020077289A1 (en) * 2000-06-02 2002-06-20 Macdonald Nicholas J. Angiostatin and endostatin binding proteins and methods of use

Similar Documents

Publication Publication Date Title
JP6408051B2 (ja) 病理学バイオマーカーアッセイ
JP6100822B2 (ja) プロカルシトニンの検出のためのイムノアッセイ
US8450463B2 (en) Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
CA2133306C (en) Amplification of human mdm2 gene in human tumors
JP2598801B2 (ja) 悪性‐PTHrPの液性過カルシウム血症において活性なタンパク
EP1151307B1 (en) Methods for differentiating and monitoring parathyroid and bone status related diseases
JP2002542157A5 (https=)
JP2008513536A (ja) プロガストリンに対するモノクローナル抗体
HUE028331T2 (en) N-11 truncated β-amyloid monoclonal antibody, preparation, method and use
US9103839B2 (en) Method of determining equine NT-proBNP
JP2010502231A (ja) 血管拡張作用を欠く水利尿およびナトリウム利尿ポリペプチド
US20150125459A1 (en) Apelin peptides, antibodies thereto, and methods of use
SK154896A3 (en) Monoclonal antibody active against cd44v6 and their use
CN100430727C (zh) 测定体液中的蛋白片段
JP2006501139A5 (https=)
JP2004536831A (ja) 副甲状腺ホルモン抗体および関連した方法
CA2531995A1 (en) Methods, kits and antibodies for detecting parathyroid hormone
JP2007514655A5 (https=)
CN86105930A (zh) 受体抗体夹层检测法
Gill et al. Chromogranin A epitopes: clues from synthetic peptides and peptide mapping
JP2925479B2 (ja) 肺小細胞癌検出薬及びその使用
US6190885B1 (en) Fusion protein containing HMFG Epitop E (S)
JP6407990B2 (ja) アウグリン免疫学的検定
JP3922345B2 (ja) 生理活性ペプチド
WO2005116658A2 (en) Method for determining a tissue degradation process by detection of comp neoepitopes